Cited 0 times in
OA10.05: An Open-Label, Multicenter, Phase II Single Arm Trial of Osimertinib in NSCLC Patients with Uncommon EGFR Mutation(KCSG-LU15-09)
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cho, JH | - |
dc.contributor.author | Sun, J | - |
dc.contributor.author | Lee, S | - |
dc.contributor.author | Ahn, JS | - |
dc.contributor.author | Park, K | - |
dc.contributor.author | Park, KU | - |
dc.contributor.author | Kang, EJ | - |
dc.contributor.author | Choi, YH | - |
dc.contributor.author | Kim, KH | - |
dc.contributor.author | An, HJA | - |
dc.contributor.author | Lee, HW | - |
dc.contributor.author | Ahn, M | - |
dc.date.accessioned | 2019-12-10T06:53:46Z | - |
dc.date.available | 2019-12-10T06:53:46Z | - |
dc.date.issued | 2018 | - |
dc.identifier.issn | 1556-0864 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/17815 | - |
dc.format | application/pdf | - |
dc.language.iso | en | - |
dc.title | OA10.05: An Open-Label, Multicenter, Phase II Single Arm Trial of Osimertinib in NSCLC Patients with Uncommon EGFR Mutation(KCSG-LU15-09) | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 이, 현우 | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.1016/j.jtho.2018.08.291 | - |
dc.citation.title | Journal of thoracic oncology | - |
dc.citation.volume | 13 | - |
dc.citation.number | 10S | - |
dc.citation.date | 2018 | - |
dc.citation.startPage | S344 | - |
dc.citation.endPage | S344 | - |
dc.identifier.bibliographicCitation | Journal of thoracic oncology, 13(10S). : S344-S344, 2018 | - |
dc.embargo.liftdate | 9999-12-31 | - |
dc.embargo.terms | 9999-12-31 | - |
dc.identifier.eissn | 1556-1380 | - |
dc.relation.journalid | J015560864 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.